Phreesia, Inc.
Total Trades
224
Buys
0
Sells
202
Largest Trade
N/A
Insiders
14
Institutional Funds
177
Inst. Value
$1M+
Activist Filings
30
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Gandhi Balaji | CFO | SELL | $15K–$50K | 836 | $26.98 | Jan 17, 2025 |
| Hui Yvonne | Principal Accounti… | SELL | $1K–$15K | 362 | $26.38 | Jan 16, 2025 |
| Hui Yvonne | Principal Accounti… | SELL | $1K–$15K | 388 | $27.85 | Jan 13, 2025 |
| Roberts Evan | COO | SELL | $50K–$100K | 3K | $27.95 | Jan 10, 2025 |
| Hui Yvonne | Principal Accounti… | SELL | $1K–$15K | 288 | $28.00 | Jan 10, 2025 |
| Roberts Evan | COO | SELL | $100K–$500K | 10K | $26.89 | Jan 8, 2025 |
| Gandhi Balaji | CFO | SELL | $50K–$100K | 3K | $26.61 | Jan 8, 2025 |
| VanDuyn Amy Beth | SVP, Human Resources | SELL | $15K–$50K | 1K | $26.61 | Jan 8, 2025 |
| Indig Chaim | CEO | SELL | $100K–$500K | 5K | $26.61 | Jan 8, 2025 |
| Hoffman Allison C | General Counsel & … | SELL | $100K–$500K | 4K | $26.61 | Jan 8, 2025 |
| Linetsky David | SVP, Life Sciences | SELL | $50K–$100K | 3K | $26.61 | Jan 8, 2025 |
| Weintraub Michael | Director | SELL | $100K–$500K | 15K | $21.01 | Dec 4, 2024 |
| Weintraub Michael | Director | EXERCISE | $15K–$50K | 15K | $2.03 | Dec 4, 2024 |
| Linetsky David | SVP, Life Sciences | SELL | $15K–$50K | 1K | $20.49 | Oct 22, 2024 |
| Gandhi Balaji | CFO | SELL | $15K–$50K | 864 | $21.03 | Oct 17, 2024 |
| Hoffman Allison C | General Counsel & … | SELL | $15K–$50K | 1K | $21.03 | Oct 17, 2024 |
| Indig Chaim | CEO | SELL | $50K–$100K | 3K | $21.03 | Oct 17, 2024 |
| Linetsky David | SVP, Life Sciences | SELL | $15K–$50K | 2K | $21.03 | Oct 17, 2024 |
| Roberts Evan | COO | SELL | $15K–$50K | 2K | $21.03 | Oct 17, 2024 |
| VanDuyn Amy Beth | SVP, Human Resources | SELL | $1K–$15K | 624 | $21.03 | Oct 17, 2024 |
| Hui Yvonne | Principal Accounti… | SELL | $50K–$100K | 3K | $20.98 | Oct 17, 2024 |
| Hoffman Allison C | General Counsel & … | SELL | $100K–$500K | 14K | $26.03 | Aug 28, 2024 |
| Gunzburg Janet | Principal Accounti… | SELL | $1K–$15K | 114 | $20.24 | Jun 24, 2024 |
| Linetsky David | SVP, Life Sciences | SELL | <$1K | 27 | $20.24 | Jun 24, 2024 |
| Linetsky David | SVP, Life Sciences | SELL | $1K–$15K | 107 | $19.53 | Jun 21, 2024 |
| Gunzburg Janet | Principal Accounti… | SELL | $1K–$15K | 286 | $21.00 | May 2, 2024 |
| Gunzburg Janet | Principal Accounti… | SELL | $15K–$50K | 912 | $22.85 | Apr 19, 2024 |
| Linetsky David | SVP, Life Sciences | SELL | $1K–$15K | 269 | $22.85 | Apr 19, 2024 |
| VanDuyn Amy Beth | SVP, Human Resources | SELL | $15K–$50K | 685 | $22.86 | Apr 17, 2024 |
| Linetsky David | SVP, Life Sciences | SELL | $50K–$100K | 2K | $22.86 | Apr 17, 2024 |
| Roberts Evan | COO | SELL | $15K–$50K | 2K | $22.86 | Apr 17, 2024 |
| Hoffman Allison C | General Counsel & … | SELL | $15K–$50K | 1K | $22.86 | Apr 17, 2024 |
| Gandhi Balaji | CFO | SELL | $15K–$50K | 948 | $22.86 | Apr 17, 2024 |
| Indig Chaim | CEO | SELL | $50K–$100K | 3K | $22.86 | Apr 17, 2024 |
| Gunzburg Janet | Principal Accounti… | SELL | $50K–$100K | 3K | $23.10 | Apr 12, 2024 |
| Hoffman Allison C | General Counsel & … | SELL | $100K–$500K | 10K | $22.99 | Apr 10, 2024 |
| Gandhi Balaji | CFO | SELL | $100K–$500K | 8K | $22.62 | Apr 10, 2024 |
| Indig Chaim | CEO | SELL | $100K–$500K | 12K | $22.62 | Apr 10, 2024 |
| VanDuyn Amy Beth | SVP, Human Resources | SELL | $100K–$500K | 7K | $23.05 | Apr 10, 2024 |
| Roberts Evan | COO | EXERCISE | $15K–$50K | 23K | $2.03 | Apr 10, 2024 |
| Roberts Evan | COO | SELL | $100K–$500K | 7K | $22.62 | Apr 10, 2024 |
| Linetsky David | SVP, Life Sciences | SELL | $50K–$100K | 4K | $22.62 | Apr 10, 2024 |
| Gunzburg Janet | Principal Accounti… | SELL | $100K–$500K | 5K | $23.03 | Apr 10, 2024 |
| Gandhi Balaji | CFO | SELL | $50K–$100K | 4K | $23.21 | Mar 27, 2024 |
| Roberts Evan | COO | SELL | $500K+ | 26K | $23.52 | Mar 25, 2024 |
| Gunzburg Janet | Principal Accounti… | SELL | $1K–$15K | 137 | $23.66 | Mar 21, 2024 |
| Linetsky David | SVP, Life Sciences | SELL | <$1K | 30 | $23.66 | Mar 21, 2024 |
| Linetsky David | SVP, Life Sciences | SELL | $1K–$15K | 448 | $23.16 | Mar 20, 2024 |
| Gunzburg Janet | Principal Accounti… | SELL | $1K–$15K | 480 | $28.00 | Feb 13, 2024 |
| Gunzburg Janet | Principal Accounti… | SELL | $1K–$15K | 480 | $27.00 | Feb 6, 2024 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 177 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Capital International Investors | 2.9M | $1M+ | SH |
| Champlain Investment Partners, LLC | 1.6M | $1M+ | SH |
| STATE STREET CORP | 1.5M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 1.0M | $1M+ | SH |
| Prosight Management, LP | 977K | $1M+ | SH |
| GW&K Investment Management, LLC | 972K | $1M+ | SH |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 899K | $1M+ | SH |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 857K | $1M+ | SH |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 813K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 579K | $1M+ | SH |
| Park West Asset Management LLC | 523K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 488K | $1M+ | SH |
| RIVERBRIDGE PARTNERS LLC | 459K | $1M+ | SH |
| CAMBIAR INVESTORS LLC | 358K | $1M+ | SH |
| ACADIAN ASSET MANAGEMENT LLC | 338K | $1M+ | SH |
| TUDOR INVESTMENT CORP ET AL | 337K | $1M+ | SH |
| ArrowMark Colorado Holdings LLC | 328K | $1M+ | SH |
| PANAGORA ASSET MANAGEMENT INC | 305K | $1M+ | SH |
| Squarepoint Ops LLC | 291K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D · Feb 19, 2026
9.2%
5.6M shares
Capital International Investors
SC 13G/A · Feb 13, 2026
4.7%
2.9M shares
SC 13G/A · Feb 5, 2026
10.1%
6.1M shares
SC 13G/A · Jan 8, 2026
0.6%
363K shares
SC 13G/A · Nov 13, 2025
6.5%
3.9M shares
SC 13G/A · Nov 5, 2025
6.5%
3.9M shares
SC 13G/A · Oct 30, 2025
9.5%
5.7M shares
Capital International Investors
SC 13G · Aug 13, 2025
5.3%
3.1M shares
Champlain Investment Partners, LLC
SC 13G · Aug 12, 2025
4.6%
2.7M shares
SC 13G/A · Aug 6, 2025
8.1%
4.8M shares
SC 13G/A · Jul 8, 2025
4.3%
2.5M shares
Champlain Investment Partners, LLC
SC 13G · May 14, 2025
5.0%
2.9M shares
SC 13G · May 14, 2025
5.0%
3.0M shares
SC 13G/A · May 12, 2025
9.7%
5.7M shares
SC 13G/A · Apr 22, 2025
6.5%
3.8M shares
SC 13G/A · Apr 17, 2025
7.0%
4.1M shares
SC 13G/A · Nov 12, 2024
11.4%
6.6M shares
SC 13G/A · Nov 8, 2024
9.1%
5.2M shares
SC 13G/A · Oct 21, 2024
9.1%
5.2M shares
Brown Advisory Incorporated ("BAI") 52-2112409
SC 13G/A · Jul 8, 2024
0.0%
5.8M shares
T. Rowe Price Investment Management, Inc. 85-4328500
SC 13G/A · Feb 16, 2024
3.3%
1.8M shares
T. Rowe Price Investment Management, Inc. 85-4328500
SC 13G · Feb 14, 2024
3.3%
1.8M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
8.3%
4.6M shares
SC 13G/A · Jan 26, 2024
7.6%
4.3M shares
T. Rowe Price Investment Management, Inc. 85-4328500
SC 13G · Feb 14, 2023
5.1%
2.7M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2023
0.3%
180K shares
Brown Advisory Incorporated ("BAI") 52-2112409
SC 13G · Feb 9, 2023
5.8%
3.1M shares
SC 13G/A · Jan 25, 2023
8.7%
4.6M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Aug 10, 2022
6.6%
3.5M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G/A · Feb 14, 2022
15.2%
7.8M shares